Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis.
<h4>Background</h4>Arthritis seriously affects people's quality of life, and there is an urgent clinical need to improve the efficacy of medications as well as to reduce the adverse effects induced by treatment. Combined colchicine therapy is gradually being embraced in clinical car...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316126 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841533122898821120 |
|---|---|
| author | Changwei Zhao Xiaogang Hao Wenjun Cai Ling-Feng Zeng Wenhai Zhao Xiangxin Li |
| author_facet | Changwei Zhao Xiaogang Hao Wenjun Cai Ling-Feng Zeng Wenhai Zhao Xiangxin Li |
| author_sort | Changwei Zhao |
| collection | DOAJ |
| description | <h4>Background</h4>Arthritis seriously affects people's quality of life, and there is an urgent clinical need to improve the efficacy of medications as well as to reduce the adverse effects induced by treatment. Combined colchicine therapy is gradually being embraced in clinical care, but the evidence remains insufficient.<h4>Methods</h4>English databases were searched from the establishment to September 4, 2024. Eleven eligible Randomized controlled trials (RCTs) were included. The quality of the literature was assessed by the risk of bias tool in the Cochrane Handbook. Relative risk (RR) and Cohen's d (SMD) were used for categorical and continuous variables, respectively, at 95% confidence interval (CI), and Stata 17.0 software was used for statistical analysis. Sensitivity analyses were used to verify the stability of the analyzed results, and heterogeneity analyses were used to explore the sources of heterogeneity in the studies. Funnel plots and Egger's test were used to assess publication bias.<h4>Results</h4>Eleven eligible RCTs were included in this study. Compared with conventional treatment, combined colchicine treatment improved patient's global assessment results (SMD = 1.24, 95% CI [0.01, 2.47], P = 0.05, I2 = 0]), stiffness (SMD = -0.81, 95% CI [-1.43, -0.19], P = 0.01, I2 = 63.91%]) and did not increase adverse effects (RR = 0.79, 95% CI [0.31, 1.27], P = 0.36, I2 = 0.00%). However, combined colchicine treatment did not improve visual analog scores (VAS) (SMD = -0.96, 95% CI [-2.85, 0.93], P = 0.13, I2 = 97.99%]), Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain (SMD = 0.01, 95% CI [-0.24, 0.27], P = 0.91, I2 = 0]), WOMAC function (SMD = -0.01, 95% CI [-0.36, 0.16], P = 0.44, I2 = 0]), Total WOMAC scale (SMD = -0.05, 95% CI [-0.33, 0.22], P = 0.70, I2 = 0]), physician 's global assessment (SMD = 0.36, 95% CI [-2.27, 3.00], P = 0.79, I2 = 97.04%]) and Modified Clinical Health Assessment Questionnaire (ModHAD) (SMD = -1.72, 95% CI [-4.90,1.45], P = 0.29, I2 = 99.11%]).<h4>Conclusion</h4>Compared with colchicine alone, combination therapy improves patients' quality of life without increasing the incidence of adverse events. |
| format | Article |
| id | doaj-art-cb88db5bd1c44c87b6ee72ef22bb693f |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-cb88db5bd1c44c87b6ee72ef22bb693f2025-01-17T05:31:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031612610.1371/journal.pone.0316126Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis.Changwei ZhaoXiaogang HaoWenjun CaiLing-Feng ZengWenhai ZhaoXiangxin Li<h4>Background</h4>Arthritis seriously affects people's quality of life, and there is an urgent clinical need to improve the efficacy of medications as well as to reduce the adverse effects induced by treatment. Combined colchicine therapy is gradually being embraced in clinical care, but the evidence remains insufficient.<h4>Methods</h4>English databases were searched from the establishment to September 4, 2024. Eleven eligible Randomized controlled trials (RCTs) were included. The quality of the literature was assessed by the risk of bias tool in the Cochrane Handbook. Relative risk (RR) and Cohen's d (SMD) were used for categorical and continuous variables, respectively, at 95% confidence interval (CI), and Stata 17.0 software was used for statistical analysis. Sensitivity analyses were used to verify the stability of the analyzed results, and heterogeneity analyses were used to explore the sources of heterogeneity in the studies. Funnel plots and Egger's test were used to assess publication bias.<h4>Results</h4>Eleven eligible RCTs were included in this study. Compared with conventional treatment, combined colchicine treatment improved patient's global assessment results (SMD = 1.24, 95% CI [0.01, 2.47], P = 0.05, I2 = 0]), stiffness (SMD = -0.81, 95% CI [-1.43, -0.19], P = 0.01, I2 = 63.91%]) and did not increase adverse effects (RR = 0.79, 95% CI [0.31, 1.27], P = 0.36, I2 = 0.00%). However, combined colchicine treatment did not improve visual analog scores (VAS) (SMD = -0.96, 95% CI [-2.85, 0.93], P = 0.13, I2 = 97.99%]), Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain (SMD = 0.01, 95% CI [-0.24, 0.27], P = 0.91, I2 = 0]), WOMAC function (SMD = -0.01, 95% CI [-0.36, 0.16], P = 0.44, I2 = 0]), Total WOMAC scale (SMD = -0.05, 95% CI [-0.33, 0.22], P = 0.70, I2 = 0]), physician 's global assessment (SMD = 0.36, 95% CI [-2.27, 3.00], P = 0.79, I2 = 97.04%]) and Modified Clinical Health Assessment Questionnaire (ModHAD) (SMD = -1.72, 95% CI [-4.90,1.45], P = 0.29, I2 = 99.11%]).<h4>Conclusion</h4>Compared with colchicine alone, combination therapy improves patients' quality of life without increasing the incidence of adverse events.https://doi.org/10.1371/journal.pone.0316126 |
| spellingShingle | Changwei Zhao Xiaogang Hao Wenjun Cai Ling-Feng Zeng Wenhai Zhao Xiangxin Li Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis. PLoS ONE |
| title | Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis. |
| title_full | Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis. |
| title_fullStr | Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis. |
| title_full_unstemmed | Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis. |
| title_short | Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis. |
| title_sort | colchicine combination therapy increases treatment tolerance in patients with arthritis a systematic review and meta analysis |
| url | https://doi.org/10.1371/journal.pone.0316126 |
| work_keys_str_mv | AT changweizhao colchicinecombinationtherapyincreasestreatmenttoleranceinpatientswitharthritisasystematicreviewandmetaanalysis AT xiaoganghao colchicinecombinationtherapyincreasestreatmenttoleranceinpatientswitharthritisasystematicreviewandmetaanalysis AT wenjuncai colchicinecombinationtherapyincreasestreatmenttoleranceinpatientswitharthritisasystematicreviewandmetaanalysis AT lingfengzeng colchicinecombinationtherapyincreasestreatmenttoleranceinpatientswitharthritisasystematicreviewandmetaanalysis AT wenhaizhao colchicinecombinationtherapyincreasestreatmenttoleranceinpatientswitharthritisasystematicreviewandmetaanalysis AT xiangxinli colchicinecombinationtherapyincreasestreatmenttoleranceinpatientswitharthritisasystematicreviewandmetaanalysis |